Patent Assignment
Reel/Frame 024233/0094
Change of Name
Recorded: 2010-04-14
Pages: 8
Assignor
TRIPEP AB
Executed: 2010-03-16
Assignee
CHRONTECH PHARMA AB
HALSOVAGEN 7, HUDDINGE, 141 57, SWEDEN
Covered Properties
(43)
Peptides for Use in Induction of T Cell Activation Against Hiv-1
Patent:
5,346,989 →
Application:
08/121,032 →
Peptides for Induction of Neutralizing Antibodies Against Human Immunodeficiency Virus
Patent:
5,589,175 →
Application:
08/410,384 →
Peptides for Use in Vaccination and Induction of Neutralizing Antibodies Against Human Immunodeficiency Virus
Patent:
5,840,313 →
Application:
08/493,235 →
Peptides That Block Human Immunodeficiency Virus and Methods of Use Thereof
Patent:
5,627,035 →
Application:
08/494,763 →
Antigen/Antibody Specificity Exchanger
Patent:
5,869,232 →
Application:
08/737,085 →
Antigen/Antibody Specificity Exchanger
Patent:
6,040,137 →
Application:
09/246,258 →
Antigen/antibody specificity exchanger
Patent:
6,245,895 →
Application:
09/532,106 →
Synthetic Peptides That Bind to the Hepatitis B Virus Core and E Antigens
Patent:
6,417,324 →
Application:
09/556,605 →
Ligand/Receptor Specificity Exchangers That Redirect Antibodies to Receptors on a Pathogen
Patent:
6,660,842 →
Application:
09/664,945 →
Antigen/Antibody Specificity Exchanger
Vaccines Containing Ribavirin and Methods of Use Thereof
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Pentamer Peptide Amide, Algpg-NH2, That Inhibits Viral Infectivity and Methods of Use Thereof
Patent:
6,455,670 →
Application:
09/948,372 →
Vaccines Containing Ribavirin and Methods of Use Thereof
Pentamer Peptide Amide, ALGPGNH2, Which Inhibits Viral Infectivity and Methods of Use Thereof
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Specificity Exchangers That Redirect Antibodies to Bacterial Adhesion Receptors
Antiviral Composition Comprising Glycine Amide
Glycosylated Ligand/Receptor Specificity Exchangers Specific for Bacterial Adhesion Receptors
Vaccines Containing Ribavirin and Methods of Use Thereof
Glycosylated Specificity Exchangers
Vaccines Containing Ribavirin and Methods of Use Thereof
Glycosylated Specificity Exchangers
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Vaccines Containing Ribavirin and Methods of Use Thereof
Glycosylated Specificity Exchangers
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Glycosylated Specificity Exchangers
Vaccines Containing Ribavirin and Methods of Use Thereof
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Compounds That Inhibit Replication Of Human Immunodeficiency Virus
Application:
11/660,429 →
Publication:
US 2008/0076824
Transgenic Mouse Models of Hepatitis C Virus (Hcv) and Identification of Hvc Therapeutics
Transdermal Formulations Containing Hepatitis C Virus Immunogens
Application:
11/915,140 →
Hepatitis C Virus Non-Structural NS3/4A Fusion Gene
Indentification of Compounds That Inhibit Replication of Human Immunodeficiency Virus
Application:
11/929,695 →
Publication:
US 2009/0170953
Glycosylated Specificity Exchanger
Application:
11/930,860 →
Publication:
US 2009/0305949
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Glycosylated Specificity Exchangers That Induce an Antibody Dependent Cellular Cytotoxicity (Adcc) Response
Application:
12/055,187 →
Publication:
US 2009/0092631
Immunogen Platform
Immunogen Platform
Application:
12/371,898 →
Publication:
US 2009/0214593
Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene
Glycosylated Specificity Exchangers
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 1994
From: SYNTELLO VACCINE DEVELOPMENT KB
To: SYNTELLO VACCINE DEVELOPMENT AB
Reel/Frame 007058/0286 →
Assignment of Assignor's Interest
Oct 7, 1998
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 009502/0400 →
Assignment of Assignor's Interest
Nov 5, 1999
From: SYNTELLO VACCINE DEVELOPMENT AB
To: TRIPEP AB
Reel/Frame 010360/0348 →
Assignment of Assignor's Interest
Nov 10, 1999
From: SYNTELLO VACCINE DEVELOPMENT AB
To: TRIPEP AB
Reel/Frame 010371/0700 →
Assignment of Assignor's Interest
Aug 8, 2000
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 011040/0176 →
Assignment of Assignor's Interest
Jan 25, 2001
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 011469/0368 →
Assignment of Assignor's Interest
Jan 18, 2002
From: VAN DER SPOEL, DAVID; HETENYI, CSABA; VEGVARI, AKOS; HOGLUND, STEFAN
To: TRIPEP AB
Reel/Frame 012469/0617 →
Assignment of Assignor's Interest
Oct 18, 2002
From: VAN DER SPOEL, DAVID; HETENYI, CSABA; VEGVARI, AKOS; HOGLUND, STEFAN
To: TRIPEP AB
Reel/Frame 013419/0709 →
Assignment of Assignor's Interest
Apr 1, 2003
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 013896/0459 →
Assignment of Assignor's Interest
May 16, 2003
From: SALLBERG, MATTI; HULTGREN, CATHARINA
To: TRIPEP AB
Reel/Frame 014073/0007 →
Assignment of Assignor's Interest
May 19, 2003
From: SALLBERG, MATTI; HULTGREN, CATHARINA
To: TRIPEP AB
Reel/Frame 014075/0114 →
Assignment of Assignor's Interest
May 19, 2003
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 014076/0381 →
Assignment of Assignor's Interest
Jun 24, 2003
From: SALLBERG, MATTI; FLOCK, JAN-INGMAR
To: TRIPEP AB
Reel/Frame 014194/0536 →
Assignment of Assignor's Interest
Nov 3, 2003
From: SALLBERG, MATTI
To: TRIPEP AB
Reel/Frame 014650/0248 →
Assignment of Assignor's Interest
Dec 9, 2014
From: CHRONTECH PHARMA AB
To: AVAC PHARMA LIMITED
Reel/Frame 034442/0805 →
Assignment of Assignor's Interest
Dec 9, 2014
From: AVAC PHARMA LIMITED
To: CHRONTECH PHARMA AB
Reel/Frame 034442/0817 →
Assignment of Assignor's Interest
Dec 16, 2014
From: CHRONTECH PHARMA AB
To: TRIPEP AB
Reel/Frame 034521/0261 →
Security Interest
Sep 29, 2015
From: TRIPEP AB
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 036714/0719 →